Lisa Gill
Stock Analyst at JP Morgan
(0)
# 4198
Out of 5,218 analysts
134
Total ratings
38.67%
Success rate
-6.34%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Surgery Partners | Maintains: Neutral | 38 28 | 20.36 | 37.52% | 4 | Dec 3, 2024 | |
Privia Health Gr | Maintains: Overweight | 27 28 | 20.93 | 33.78% | 4 | Nov 29, 2024 | |
PACS Group | Reinstates: Overweight | 40 | 15.41 | 159.57% | 1 | Nov 6, 2024 | |
Walgreens Boots Alli... | Maintains: Overweight | 20 15 | 10.42 | 43.95% | 14 | Aug 30, 2024 | |
Teladoc Health | Maintains: Neutral | 16 9 | 10.41 | -13.54% | 9 | Aug 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 22 18 | 13.9 | 29.5% | 4 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 656 661 | 576.49 | 14.66% | 10 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 332 396 | 273.6 | 44.74% | 5 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 435 438 | 281.79 | 55.43% | 9 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 280 287 | 232.37 | 23.51% | 1 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 111 123 | 118.15 | 4.1% | 4 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 20.5 | 41.46% | 1 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 18 | 16.71 | 7.72% | 1 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 420 395 | 303.12 | 30.31% | 2 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 261 243 | 232.46 | 4.53% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 101 86 | 49.39 | 74.12% | 4 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 182 186 | 187.25 | -0.67% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 546 559 | 521.04 | 7.29% | 5 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 107 140 | 136.7 | 2.41% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 152 155 | 155.09 | -0.06% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 327 332 | 314.03 | 5.72% | 3 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 628 631 | 380.91 | 65.66% | 4 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 6 | 4.42 | 35.75% | 3 | Mar 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 7 10 | 4.71 | 112.31% | 1 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 9 | 2.24 | 301.79% | 3 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 8 | 7.17 | 11.58% | 4 | Nov 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 46 44 | 23.5 | 87.23% | 2 | Oct 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 83 | 76.59 | 8.37% | 1 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 10 | 11.42 | -12.43% | 3 | Jul 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 191 198 | n/a | n/a | 4 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 39 | n/a | n/a | 1 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 98 | 59.46 | 64.82% | 1 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 41 28 | n/a | n/a | 2 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 21 12 | n/a | n/a | 4 | Jun 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 74 | n/a | n/a | 3 | Mar 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 26 24 | 31.05 | -22.71% | 4 | Jun 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 19, 2017 |